Evidence mapPaperPMID 41807957Full record

ArticleBMC pregnancy and childbirth2026

Early gestational diabetes mellitus and type 2 diabetes: do they differ in perinatal outcome- a retrospective analysis.

Aleksandra Gladych-Macioszek, Urszula Mantaj, Kinga Tobola-Wrobel, Sandra Radzicka-Mularczyk, Rafal Sibiak, Lukasz Adamczak, Gernot Desoye, Ewa Wender-Ozegowska

Registry-linked trialAbstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07602036 (Type 2 Diabetes and Pregnancy a Single-arm Interventional Study), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07602036 nanot yet recruitingnot on this map

Type 2 Diabetes and Pregnancy a Single-arm Interventional Study

TypeinterventionalSponsorPoznan University of Medical SciencesRan2026 to 2029Enrolled20ConditionsPregnancy, Type 2 DiabetesArmsAutomated insulin delivery system - Medtronic 780G
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aleksandra Gladych-Macioszek *Department of Reproduction, Chair of Fetomaternal Medicine, Poznan University of Medical Sciences, Poznan, Poland. aleksandragladych@gmail.com.
Urszula Mantaj *Department of Reproduction, Chair of Fetomaternal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Kinga Tobola-WrobelDepartment of Reproduction, Chair of Fetomaternal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Sandra Radzicka-MularczykDepartment of Reproduction, Chair of Fetomaternal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Rafal SibiakDepartment of Reproduction, Chair of Fetomaternal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Lukasz AdamczakDepartment of Reproduction, Chair of Fetomaternal Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Gernot Desoye *Department of Obstetrics and Gynaecology, Medical University of Graz, Graz, Austria.
Ewa Wender-Ozegowska *Department of Reproduction, Chair of Fetomaternal Medicine, Poznan University of Medical Sciences, Poznan, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe rise in type 2 diabetes (T2D) during pregnancy is mainly due to increasing obesity and metabolic disorders. Early gestational diabetes mellitus (eGDM), diagnosed before 20 weeks, is also becoming more common and often may explain underlying metabolic problems. This study compares perinatal and neonatal outcomes in patients with T2D and eGDM.

methodsThis retrospective study included 141 pregnant women (70 with T2D and 71 with eGDM) and their singleton term neonates born between 2020 and 2025. The women attended at least one follow-up visit per trimester. eGDM was diagnosed before 20 weeks of gestation based on an oral 75 g glucose tolerance test according to Polish recommendations. Each patient had their HbA1c levels measured at the time of diagnosis and then in each trimester of pregnancy. As a comparator, we used our university hospital growth charts and calculated neonatal growth data from healthy women who delivered at the same hospital between 2017 and 2022. Statistical analysis was performed using PQStat, with p-values < 0.05 considered statistically significant.

resultsPre-pregnancy obesity was more common in the eGDM group (94.4% vs. 77.1%,p < 0.05). Women with T2D gained more weight (p < 0.005) and had higher HbA1c levels throughout pregnancy (p < 0.005) than those with eGDM. Insulin was required more often in women with T2D (98.6% vs. 63.4%, p < 0.05) and started earlier in T2D (9 vs. 15 weeks, p < 0.005). Preterm birth rates were similar in the T2D and eGDM groups 12.7% vs. 15.7%), as were cesarean section rates (62.9% vs. 60.6%), LGA (15.7% vs. 26.8% according to local growth charts) and SGA (20% vs. 26.8% according to local growth charts). Neonatal jaundice was less frequent in the T2D group (21.4% vs. 36.8%, p < 0.05). Congenital defects occurred at a similar frequency in both groups (T2D: 5.6% vs. eGDM: 8.6%).

conclusionsThe study groups differed significantly in weight gain during pregnancy, the need for and onset of insulin administration, and the incidence of jaundice in newborns. Prepregnancy obesity in the eGDM group may be the main factor predisposing to the trend to a higher percentage of LGA babies in this group. The frequency of congenital malformations in both groups reinforces the need for pre-conception counselling for their prevention.

Indexed as

Diabetes, GestationalDiabetes Mellitus, Type 2Pregnancy OutcomeAdultFemaleGlucose Tolerance TestGlycated HemoglobinHumansInfant, Large for Gestational AgeInfant, NewbornObesityPregnancyRetrospective StudiesGlycated HemoglobinEarly gestational diabetesNeonatal outcomesPerinatal outcomesType 2 diabetes

Identifiers

PMID41807957
PMCPMC13088713

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.